Condition 101 About Acute Myeloblastic Leukemia with Maturation

What are the alternative names for Acute Myeloblastic Leukemia with Maturation?

  • Acute myeloblastic leukemia type 2
  • Acute myeloblastic leukemia M2
  • AML M2
  • LAM M2

Latest Advances On Acute Myeloblastic Leukemia with Maturation

  • Condition: Acute Myeloid Leukemia (AML)
  • Journal: Medicine
  • Treatment Used: Intermediate Dose (ID) Cytarabine
  • Number of Patients: 52
  • Published —
This study investigated the toxic effects of a single-intermediate dose (ID) cytarabine in patients with acute myeloid leukemia (AML) after complete remission (CR).
  • Condition: Patients with Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)
  • Journal: Hematology (Amsterdam, Netherlands)
  • Treatment Used: Venetoclax (VEN) in Combination with Hypomethylating Agents (HMAs)
  • Number of Patients: 1059
  • Published —
This study evaluated the effectiveness and adverse effects of venetoclax (VEN) in combination with hypomethylating agents (HMAs) in patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS).

Clinical Trials For Acute Myeloblastic Leukemia with Maturation

Clinical Trial
  • Status: Not yet recruiting
  • Phase: Phase 2
  • Intervention Type: Other, Drug, Radiation, Procedure, Biological
  • Participants: 240
  • Start Date: June 1, 2021
A Randomized Phase II Study to Compare ATG or Post-Transplant Cyclophosphamide to Calcineurin Inhibitor-Methotrexate as GVHD Prophylaxis After Myeloablative Unrelated Donor Peripheral Blood Stem Cell Transplantation
Clinical Trial
  • Status: Not yet recruiting
  • Phase: N/A
  • Intervention Type: Behavioral
  • Participants: 20
  • Start Date: May 31, 2021
A Telehealth Advance Care Planning Intervention for Older Patients With Acute Myeloid Leukemia and Myelodysplastic Syndrome